Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5277807
Max Phase: Preclinical
Molecular Formula: C17H8Cl2N6O3
Molecular Weight: 415.20
Associated Items:
ID: ALA5277807
Max Phase: Preclinical
Molecular Formula: C17H8Cl2N6O3
Molecular Weight: 415.20
Associated Items:
Canonical SMILES: N#Cc1nn(-c2cc(Cl)c(-n3ccc4[nH]c(=O)ccc43)c(Cl)c2)c(=O)[nH]c1=O
Standard InChI: InChI=1S/C17H8Cl2N6O3/c18-9-5-8(25-17(28)22-16(27)12(7-20)23-25)6-10(19)15(9)24-4-3-11-13(24)1-2-14(26)21-11/h1-6H,(H,21,26)(H,22,27,28)
Standard InChI Key: UXUMSDHCPJHVFP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 415.20 | Molecular Weight (Monoisotopic): 414.0035 | AlogP: 1.73 | #Rotatable Bonds: 2 |
Polar Surface Area: 129.33 | Molecular Species: ACID | HBA: 7 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 5.65 | CX Basic pKa: | CX LogP: 2.91 | CX LogD: 1.37 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.52 | Np Likeness Score: -1.35 |
1. Hu L, Gu Y, Liang J, Ning M, Yang J, Zhang Y, Qu H, Yang Y, Leng Y, Zhou B.. (2023) Discovery of Highly Potent and Selective Thyroid Hormone Receptor β Agonists for the Treatment of Nonalcoholic Steatohepatitis., 66 (5): [PMID:36799411] [10.1021/acs.jmedchem.2c01669] |
Source(1):